Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

64
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
64
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

627
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
627
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

104
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
104
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

72
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
72
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposure-response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis.

Journal of endocrinological investigation·2023
Same author

A review of modeling pesticides in freshwaters: Current status, progress achieved and desirable improvements.

Environmental pollution (Barking, Essex : 1987)·2022
Same author

The relationship between thyroid disorders and vitamin A.: A narrative minireview.

Frontiers in endocrinology·2022
Same author

A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model.

The Journal of antimicrobial chemotherapy·2022
Same author

<i>In vivo</i> / <i>in vitro</i> Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model.

Frontiers in pharmacology·2021

Related Experiment Video

Updated: Jun 16, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

Model-informed precision dosing: State of the art and future perspectives.

I K Minichmayr1, E Dreesen2, M Centanni3

  • 1Dept. of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Advanced Drug Delivery Reviews
|August 19, 2024
PubMed
Summary

Model-informed precision dosing (MIPD) personalizes medication by integrating mathematical models and patient data, advancing beyond traditional drug monitoring. Rigorous validation is key to its clinical application for better patient outcomes.

Keywords:
Anti-infectivesImmunosuppressionInflammatory bowel diseaseModel-informed precision dosingOncology

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

815

Related Experiment Videos

Last Updated: Jun 16, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

815

Area of Science:

  • Pharmacology
  • Personalized Medicine
  • Computational Biology

Background:

  • Model-informed precision dosing (MIPD) represents an advancement in personalized medicine, aiming to optimize drug regimens for individual patients.
  • MIPD integrates mathematical modeling with patient-specific data, surpassing traditional therapeutic drug monitoring (TDM) by accounting for variability.

Purpose of the Study:

  • To review novel methodologies in model selection and validation for MIPD.
  • To explore the integration of machine learning, biosensors, and biomarkers in enhancing precision dosing.
  • To discuss the clinical evidence and future directions for MIPD across various medical disciplines.

Main Methods:

  • Review of current literature on model qualification, selection, and validation techniques for MIPD.
  • Exploration of emerging technologies such as machine learning algorithms and biosensors for real-time drug monitoring.
  • Analysis of pharmacokinetic/pharmacodynamic (PK/PD) principles and biomarker integration in precision dosing models.

Main Results:

  • MIPD offers a sophisticated approach to tailoring drug doses by incorporating patient characteristics, drug measurements, and variability.
  • Machine learning and biosensors show promise for improving the accuracy and real-time application of MIPD.
  • Biomarker integration can further refine MIPD for predicting drug efficacy and toxicity.

Conclusions:

  • Rigorous model qualification is essential for the safe and effective clinical implementation of MIPD.
  • Evidence for TDM and MIPD exists across infection medicine, oncology, transplant medicine, and inflammatory bowel diseases.
  • Further research, including randomized clinical trials, is needed to confirm MIPD's benefits in improving patient outcomes and advancing personalized medicine.